StocksBluebird Bio IncBLUE

BLUE

Bluebird Bio Inc

2.94 -0.26 (-8.13%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
BLUE
BLUE
FeedStatsChartResearchNewsNew
S
2.94
B
2.97

Overview

Prev Close2.94
Day's Range 2.92 - 3.11
52 Week Range 2.92 - 35.52
Average Volume (3m)2.39M
1-Year Return-90.36%
Beta1.183
Market Cap228.65M
P/E Ratio
Revenue33.7M
EPS-10.5375
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.714/12/202124/02/202205/05/20224.006.008.0010.0012.00
Chart times in UTC
Sector
Health Technology
Industry Biotechnology
CEO Andrew Obenshain, MBA
Employees 518

FINANCIAL SUMMARY

For the quarter ended 31/3/2022, Bluebird Bio Inc's revenues increased by 21.11% and amounted to 1.95M. Net income increased by 7.69% to -122.15M. Net assets decreased by 29.66% to 263.26M and EPS increased from -2.14 to -1.66.
BLUE's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
-69.34%
Net Profit Margin
-3,819.43%
Operating Margin
-2,055.00%
Return On Investment
-53.56%
06/21
09/21
12/21
03/22
Total Revenue
7.47M
22.68M
1.61M
1.95M
Gross Profit
-23.89M
-3.01M
-2.08M
-7.38M
Operating Income
-240.79M
N/A
-134.67M
-120.35M
Net Income
-241.7M
-216.82M
-132.33M
-122.15M